| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Fundraising > Your Fundraising Annual Appeal Letters Need A Villian |
|
Advice You - Your Fundraising Annual Appeal Letters Need A Villian
Anger is one of the best emotions that you can arouse in a donor. Anger is a healthy emotion, particularly when your fundraising let According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ter offers donors a way to assuage their anger. “Individuals are more prone to respond to a genuine feeling of anger than to any oth ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in er emotion,” says Roland Kiniholm in his book, Maximum Gifts by Return Mail. To make your donors angry, you need a villain lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. . Villains are good. They help you focus your donors’ attention on one problem that needs fixing. That villain can be a person or a here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe roblem. My advice is that you never name a particular person as your villain, since doing so is not very charitable, excuse the pun d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro . Plus, you might get sued for defamation of character or slander. Instead, you should attack the catastrophe that the villain has c ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc reated, or simply make the catastrophe the villain.
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi en drivers)
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically poverty (not the wealthy)
Hurricane and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ Katrina hit the Gulf Coast of the United States last week. The response by the US federal government to the plight of tens of thous ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ands of refugees stranded in New Orleans was so slow that hundreds likely perished. For days, we saw the images on our television sc ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a reens of stranded citizens dying in New Orleans while help tarried. In your fundraising letter to raise funds for these hurricane v dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ctims, you could name President Bush as your villain. You could blame the plight of the displaced people on Federal Emergency Manage cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ment Agency director Michael Brown, who many are saying is responsible for the delays that caused so many deaths. Or you could blame tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen the mayor of New Orleans. But these attacks would sound unkind. And painting any of these men as the villain right now would be pre t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel mature. Instead, a successful appeal letter would paint the hurricane as the villain. Or point the finger at the flooding as the vi ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust lain. Your fundraising campaign can have a villain and still be positive. The Red Cross, for example, is running a fundraising camp y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products aign right now with this theme: Hope is Stronger than a Hurricane. There’s only one thing wrong with that theme. I didn’t think of i . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de t. If you want to stir up one of the strongest human emotions to your advantage, chose a villain that your donors can get angry at. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip Then show how your non-profit organization can alleviate that anger by eliminating (or, more realistically, weakening) that villain tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Importance of Good Wheel Castors for Office Chairs With a Grain of Salt (Because You Can't Always Believe Everything You Hear or Read) How Mean is your Lean? Results of UK Study in Manufacturing
|